The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids
Journal Title: Annals of Hepatology - Year 2018, Vol 17, Issue 3
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease nowadays with currently no approved therapies for the disease. The liver plays a pivotal role in lipid and glucose metabolism. The interactions of molecular mechanisms on the gut for example influences the development still needs to be understood. Bile acids (BA) have been shown to impact metabolic homeostasis and insulin sensitivity. Here, we comment on a study analyzing BA profiles in NAFLD patients addressing novel pathways involved in NAFLD progression.<br/><br/>
Authors and Affiliations
Aline Gottlieb, Lars Bechmann, Ali Canbay
Keywords
Related Articles
- EP ID EP345205
- DOI 10.5604/01.3001.0011.7378
- Views 97
- Downloads 0
Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome?
Background &amp;amp; Aims. It is unclear whether portal vein thrombosis (PVT) unrelated to malignancy is associated with reduced survival or it is an epiphenomenon of advanced cirrhosis. The objective of this study...
Comorbidities have a limited impact on post-transplant survival in carefully selected cirrhotic patients: a population-based cohort study
Background. Improving estimation of long-term survival of patients with end-stage liver disease after orthotopic liver transplantation (OLT) would optimize decisions on eligibility for transplant. We aimed to externally...
Prognostic markers in cirrhotic patients requiring intensive care: a comparative prospective study
Introduction. The use of prognostic models for cirrhotic patients admitted to the medical intensive care unit (ICU) is of great importance, since they provide an objective evaluation for a group of patients with high mo...
Metabolic syndrome and non-alcoholic fatty liver disease
The development of nonalcoholic fatty liver disease (NAFLD) is strongly associated with the metabolic syndrome as reflected by the fact that approximately 90% of the patients with NAFLD have more than one feature of meta...
Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C?
Background. Serum levels of cystatin C, an endogenous inhibitor of cysteine proteases, provide an alternative method to creatinine-based criteria for measuring glomerular filtration rate. Preliminary data suggested that...